Article
Critically evaluated key points on hereditary medullary thyroid carcinoma.
Frontiers in endocrinology - 1 Jan 2024
Zhang Daqi, Liang Nan, Sun Hui, Frattini Francesco, Sui Chengqiu, Yang Mingyu, Wang Hongbo, Dionigi Gianlorenzo
Abstract excerpt
Medullary thyroid carcinoma (MTC) accounts for only 3% of all thyroid carcinomas: 75% as sporadic MTC (sMTC) and 25% as hereditary MTC (hMTC) in the context of multiple endocrine neoplasia type 2 (MEN2). Early diagnosis is possible by determining the tumour marker calcitonin (Ctn) when clarifying nodular goitre and by detecting the mutation in the proto-oncogene RET in the MEN2 families. If the Ctn level is only...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
